An interdisciplinary group of University of North Carolina at Chapel Hill researchers were recently awarded a grant to study and develop a novel, phytochemical-based triple-agent biomaterial designed to enhance predictable bone regeneration in oral and craniofacial applications.
The research stems from the team’s approach to “whole person health,” and it will look at the combined effect of biology and behavior in patients to see how these factors affect overall health, disease development and treatments. It will look at diet and the effects of dietary supplement.
Patricia Miguez, DDS, MS, PhD, an Adams School of Dentistry associate professor and researcher, said the research explores how a phytochemical present in citrus fruits can help with bone maintenance and bone regeneration surgeries in animal models.
“This grant was built on the knowledge of the positive effects of the phytochemical as a dietary supplement. This study aims for the development of a local delivery system for this natural product in bone defects to boost regenerative capacity while minimizing inflammation in a restricted area such as a tooth extraction site, or sites of extreme bone loss,” Miguez said.
Miguez said research is still needed to fully explore the impact of dietary choices on whole person health, and the integration of natural compounds with current therapeutics and biologics may provide better surgical and treatment outcomes and could make treatments more effective for patients while decreasing the costs associated with treating bone loss.
The research team combines expertise in several areas key to moving the study forward, including dentistry, chemistry, periodontology, bone physiology and biomaterials.
“This proposal is unique because it brings together an expert team in a quest to develop a cost-effective tissue engineering approach, which are still largely ineffective and unpredictable today,” Miguez said.
Source: https://dentistry.unc.edu/
Editorials 22 October 2025
She will examine how Medicaid adult dental coverage and preventive dental visits influence diagnosis and survival outcomes for oral and pharyngeal cancers.
Implantology 17 October 2025
To investigate whether cross-section imaging influences the planning and therapy of standard implant cases in the posterior mandible.
Oral surgery 22 September 2025
Minor oral surgical procedures in patients on oral anticoagulants—a controlled study
Patients on therapeutic anticoagulation are at risk of bleeding from minor oral surgical sites.
News 09 September 2025
Chemomouthpiece, LLC, a privately held medical device company that develops and commercializes supportive cancer care products, today announced that the peer-reviewed results from its pivotal,...
Editorials 25 August 2025
Dr. Joshua Emrick’s Team Sheds New Light on Protective Tooth Nerve Function in Cell Reports Study
Joshua J. Emrick, DDS, PhD, assistant professor in the Department of Biologic and Materials Sciences & Prosthodontics (BMSP), shines a spotlight on the sensory neurons in teeth in a recent...
Oral surgery 27 October 2025
The authors assessed the incidence of postoperative bleeding in patients who were highly anticoagulated and in patients who underwent extensive oral surgical procedures and who continued using oral...
With a new name, Tufts Special Care Dental Clinics continues a 50-year mission of treating people with intellectual and developmental disabilities
Ultradent Products, Inc., a leading developer and manufacturer of high-tech dental materials, is announcing the launch of VALO X Colors: new, vibrant finishes for the award-winning VALO X curing...
News 27 October 2025
OrthoFX, a leading innovator of shorter wear time aligner systems, announces AirFlex with new PrecisionFinish Aligners.
News 27 October 2025
Young Innovations Strengthens North American Leadership Team
Young Innovations, a leading global manufacturer and distributor of dental supplies and equipment, is pleased to announce two significant additions to its North American leadership team as part of...